Synopsys (SNPS) to Release Quarterly Earnings on Wednesday

Synopsys (NASDAQ:SNPS) will likely be releasing its Q4 2025 results after the market closes on Wednesday, December 10th. Analysts expect Synopsys to post earnings of $2.79 per share and revenue of $2.2497 billion for the quarter. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, December 10, 2025 at 5:00 PM ET.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the company earned $3.43 EPS. Synopsys’s revenue for the quarter was up 14.0% compared to the same quarter last year. On average, analysts expect Synopsys to post $11 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Synopsys Stock Performance

Shares of Synopsys stock opened at $449.35 on Wednesday. The business has a 50-day simple moving average of $437.96 and a 200 day simple moving average of $506.34. Synopsys has a one year low of $365.74 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The firm has a market capitalization of $83.47 billion, a price-to-earnings ratio of 35.27, a PEG ratio of 5.02 and a beta of 1.16.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SNPS. Wells Fargo & Company dropped their price objective on Synopsys from $550.00 to $445.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 25th. Baird R W downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Wall Street Zen cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. JPMorgan Chase & Co. decreased their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Finally, Needham & Company LLC cut their price target on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $556.33.

Insider Transactions at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert G. Painter acquired 350 shares of Synopsys stock in a transaction dated Thursday, September 11th. The shares were bought at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the purchase, the director directly owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. The trade was a 18.03% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders sold 19,528 shares of company stock worth $10,066,095. 0.62% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Synopsys

Institutional investors have recently bought and sold shares of the stock. Brighton Jones LLC increased its stake in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after buying an additional 50 shares during the period. Eaton Financial Holdings Company LLC purchased a new stake in Synopsys during the 3rd quarter valued at $400,000. WINTON GROUP Ltd grew its holdings in Synopsys by 9.2% in the 2nd quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company’s stock worth $389,000 after acquiring an additional 64 shares during the last quarter. Eisler Capital Management Ltd. purchased a new position in shares of Synopsys in the third quarter valued at about $385,000. Finally, Qtron Investments LLC purchased a new position in shares of Synopsys in the third quarter valued at about $337,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.